Assessment of the effect of chemotherapy and radiotherapy on the auditory function of children with cancer.
Forty children with malignant disease underwent full audiological assessment with pure tone audiometry, tympanometry and measurement of brain stem auditory evoked potentials in an attempt to detect auditory dysfunction resulting from treatment. Significant auditory dysfunction was observed in 8 children. Three children with evidence of a conductive or sensorineural deafness on pure tone audiometry had normal brain stem evoked potentials. One child with a high tone hearing loss and 4 children with no detectable hearing loss on audiometry showed significant differences in the interaural interpeak latencies of selected brain stem auditory evoked potentials. In 2 children these abnormalities had resolved on subsequent testing, 2 had evidence of persistent retrocochlear dysfunction and the remaining child died prior to further evaluation. Routine measurement of brain stem auditory evoked potentials is probably not necessary for the majority of children undergoing treatment for cancer, although such measurements are of value when differentiation between cochlear and retrocochlear damage is required.
D000158:Acoustic Impedance Tests; D000293:Adolescent; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001300:Audiometry, Evoked Response; D001301:Audiometry, Pure-Tone; D002648:Child; D002675:Child, Preschool; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D034381:Hearing Loss / Q000209:etiology*; D006314:Hearing Loss, Conductive / Q000209:etiology*; D006319:Hearing Loss, Sensorineural / Q000209:etiology*; D006801:Humans; D011446:Prospective Studies; D011878:Radiotherapy / Q000009:adverse effects*; D012189:Retrospective Studies
D000970:Antineoplastic Agents